|
VTGN Vistagen Therapeutics Inc 1411685 |
| Balance Sheet |
|
Current Assets
|
89,941,000 |
|
Assets
|
92,307,000 |
|
Current Liabilities
|
9,621,000 |
|
Liabilities
|
11,185,000 |
|
Equity
|
81,122,000 |
|
Shares Out
|
27,055,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-32,035,000 |
|
Investing Cash Flow
|
-13,675,000 |
| Market Analysis |
Market Cap
|
83,735,535 |
|
Price
|
2.64 |
|
BVPS
|
3.00 |
|
PB
|
0.91 |
|
EPS
|
-1.53 |
|
PS
|
89.46 |
|
FCF
|
-45,710,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VTGN documents filed with the SEC.
VTGN Filings
Clear
